Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9504647 | FERRING PHARMS INC | Pharmaceutical formulations of desmopressin |
May, 2023
(10 months ago) | |
US9220747 | FERRING PHARMS INC | Methods using desmopressin acetate in orodispersible form |
May, 2023
(10 months ago) | |
US9919025 | FERRING PHARMS INC | Pharmaceutical formulations of desmopressin |
May, 2023
(10 months ago) | |
US10307459 | FERRING PHARMS INC | Pharmaceutical formulations of desmopressin |
May, 2023
(10 months ago) | |
US7947654 | FERRING PHARMS INC | Pharmaceutical formulations |
Dec, 2023
(2 months ago) | |
US8802624 | FERRING PHARMS INC | Methods of treatment using orodispersible desmopressin pharmaceutical formulations |
Dec, 2023
(2 months ago) | |
US7560429 | FERRING PHARMS INC | Orodispersible dosage forms of desmopressin acetate |
Feb, 2024
(a month ago) | |
US10137167 | FERRING PHARMS INC | Methods comprising desmopressin |
May, 2029
(5 years from now) | |
US11020448 | FERRING PHARMS INC | Methods comprising desmopressin |
May, 2029
(5 years from now) | |
US9974826 | FERRING PHARMS INC | Methods comprising desmopressin |
Apr, 2030
(6 years from now) |
Market Authorisation Date: 21 June, 2018
Treatment: Treatment of nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults, comprising monitoring a patient's serum sodium concentration
Dosage: TABLET;SUBLINGUAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7405203 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
May, 2023
(10 months ago) | |
US7579321 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
May, 2023
(10 months ago) | |
US7799761 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
Sep, 2024
(5 months from now) | |
US11419914 | SERENITY PHARMS LLC | Safe desmopressin administration |
Jun, 2030
(6 years from now) | |
US9539302 | SERENITY PHARMS LLC | Safe desmopressin administration |
Jun, 2030
(6 years from now) |
Market Authorisation Date: 03 March, 2017
Treatment: A method of treating nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void by inducing an antidiuretic e...
Dosage: SPRAY, METERED;NASAL